Cite
HARVARD Citation
Palace, J. et al. (2019). Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme. Journal of neurology, neurosurgery and psychiatry. 90 (3), pp. 251-260. [Online].